References
- Bhargava, R., Striebel, J., Beriwal, S., Flickinger, J. C., Onisko, A., Ahrendt, G., Dabbs, D. J. (2009). Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers. Int. J. Clin. Exp. Pathol., 2, 444–455.
- Cadoo, K. A., Traina, T. A., King, T. A. (2013). Advances in molecular and clinical subtyping of breast cancer and their implications for therapy. Surg. Oncol. Clin. N. Amer., 22 (4), 823–840.
- Caldarella, A., Buzzoni, C., Crocetti, E., Bianchi, S., Vezzosi, V., Apicella, P., Biancalani, M., Giannini, A., Urso, C., Zolfanelli, F., Paci E. (2013). Invasive breast cancer: A significant correlation between histological types and molecular subgroups. J. Cancer Res. Clin. Oncol., 139 (4), 617–623.
- Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway K, Karaca G., Troester, M. A., Tse, C. K., Edmiston, S., Deming, S. L., Geradts, J., Cheang, M. C., Nielsen, T. O., Moorman, P. G., Earp, H. S., Millikan, R. C. (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA (Journal of the American Medical Association), 295, 2492–2502.
- Chekhun, S., Bezdenezhnykh, N., Shvets, J., Lukianova, N. (2013). Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype. Exp. Oncol., 35 (3), 174–179.
- Ciriello, G., Sinha, R., Hoadley, K. A., Jacobsen, A S., Reva, B., Perou, C. M., Sander, C., Schultz, N. (2013). The molecular diversity of Luminal A breast tumors. Breast Cancer Res. Treat., 41 (3), 409–420.
- Desmedt, C., Sotiriou C. (2006). Proliferation: The most prominent predictor of clinical outcome in breast cancer. Cell Cycle, 5 (19), 2198–2202.
- Dreyer, G., Vandorpe, T., Smeets, A., Forceville, K., Brouwers, B., Neven, P., Janssens, H., Deraedt, K., Moerman, P, Van Calster, B., Christiaens, M. R., Paridaens, R., Wildiers H. (2013). Triple negative breast cancer: Clinical characteristics in the different histological subtypes. Breast, 22 (5), 761–766.
- El Fatemi, H., Chahbouni, S., Jayi, S., Moumna, K., Melhouf, M. A., Bannani, A., Mesbahi, O., Amarti, A. (2012). Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: An immunohistochemical profile study from Morocco. Diagn. Pathol., 7, 170.
- Edge, S. E., Byrd, D. R., Compton, C. C., Fritz A. G., Green, F. L., Frotti, A. (eds.) (2010). AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th edition. New York: Springer. 649 pp.
- Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., Senn, H. J. (2011). Strategies for subtypes dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer. Ann. Oncol., 22 (8), 1736–1747.
- Ishikawa, Y., Horiguchi, J., Toya, H., Nakajima, H., Hayashi, M., Tagaya, N., Takeyoshi, I., Oyama, T. (2011). Triple-negative breast cancer: Histological subtypes and immunohistochemical and clinicopathological features. Cancer Sci., 102 (3), 656–662.
- Lakhani, S. R., Ellis, I. O., Schnitt, S. J., Tan, P. H., van de Vijver, M. J. (eds) (2012). WHO Classification of Tumours of the Breast, Fourth Edition. International Agency for Research on Cancer. 500 pp.
- Laurinavicius, A., Laurinaviciene, A., Ostapenko, V., Dasevicius, D., Jarmalaite, S., Lazutka, J. (2012). Immunohistochemistry profiles of breast ductal carcinoma: Factor analysis of digital image analysis data. Diagn. Pathol., 7, 2–27.
- Lips, E. H., Mulder, L., de Ronde, J. J., Mandjes, I. A., Koolen, B. B., Wessels, L. F., Rodenhuis, S., Wesseling, J. (2013). Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. Breast Cancer Res. Treat., 140 (1), 63–71.
- Montagna, E., Maisonneuve, P., Rotmensz, N., Cancello, G., Iorfida, M., Balduzzi, A., Galimberti, V., Veronesi, P., Luini, A., Pruneri, G., Bottiglieri, L. A., Mastropasqua, M. G., Goldhirsch, A., Viale, G., Colleoni, M. (2013). Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome. Clin. Breast Cancer, 13 (1), 31–39.
- Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., Akslen, L., Ragaz, J., Gown, A. M., Gilks, C. B., van de Rijn M., Perou, C. M. (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res., 10, 5367–5374.
- Ng, C., Weigelt, B., Grigoriadis, A., Reis-Filho, J. S. (2012). Prognostic signatures in breast cancer: Correlation does not imply causation. Breast Cancer Res.,14 (3), 313.
- Perou, C. M., Sorlie, T., Eisen, M. B., Rijn M van de, Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lønning, P. E., Børresen-Dale, A. L., Brown, P. O., Botstein, D. (2000). Molecular portraits of human breast tumours. Nature, 406, 747–752.
- Srebnij, A., Ancans, G., Eglitis, J., Krumins, V., Graudina, L., Berzins, J., Vikmanis, U. (2011). Development of Breast-conserving surgery in breast cancer treatment in Latvia (Last 20 years experience at Latvian Oncology Centre). Acta Chirurgica Latviensis, 11, 21–27.
- Weigelt, B., Geyer, F. C., Reis-Filho, J. S. (2010). Histological types of breast cancer: How special are they? Mol. Oncol., 4 (3), 192–208.
- Weigelt, B., Horlings, H. M., Kreike, B., Hayes, M. M., Hauptmann, M., Wessels, L. F., de Jong, D., Van de Vijver, M. J., Van’t Veer, L. J., Peterse, J. L. (2008). Refinement of breast cancer classification by molecular characterization of histological special types. J. Pathol., 216 (2), 141–150.